Private equity-backed companies are expected to lead the charge in the IPO market as sponsors look to unload holdings and return capital to investors. SailPoint and parent Thoma Bravo are offering 50 ...
Maze Therapeutics ( NASDAQ: MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...
Smithfield Foods' CEO says he is watching Trump’s immigration policies closely, but he hasn’t seen any ICE raids at any of the company’s 41 plants yet.
Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...
Sports bar chain Twin Peaks starts trading Thursday on the NASDAQ using the ticker “TWNP,” making it the first restaurant initial public offering of the new year and a potential litmus test for others ...